Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roche’s Phase III Trial of Actemra in COVID-19 Misses Primary Endpoint

contractpharmaJuly 31, 2020

Tag: Roche , Actemra , COVID-19 , COVACTA

PharmaSources Customer Service